Codelivery of Adriamycin and P-gp Inhibitor Quercetin Using PEGylated Liposomes to Overcome Cancer Drug Resistance

This publication has 39 references indexed in Scilit:

• Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems
  Journal of Pharmacy and Pharmacology, 2013
• Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies
  Journal of Molecular and Cellular Cardiology, 2012
• Epirubicin: Is it like doxorubicin in breast cancer? A clinical review
  The Breast, 2012
• Effects of quercetin on the bioavailability of doxorubicin in rats: Role of CYP3A4 and P-gp inhibition by quercetin
  Archives of Pharmacal Research, 2011
• Liposomes as delivery systems for antibiotics
  International Journal of Pharmaceutics, 2010
• Quercetin pretreatment increases the bioavailability of pioglitazone in rats: Involvement of CYP3A inhibition
  Biochemical Pharmacology, 2008
• Quantitation of Doxorubicin Uptake, Efflux, and Modulation of Multidrug Resistance (MDR) in MDR Human Cancer Cells
  The Journal of Pharmacology and Experimental Therapeutics, 2008
• Enhanced bioavailability of tamoxifen after oral administration of tamoxifen with quercetin in rats
  International Journal of Pharmaceutics, 2006
• Pathology of radiation and anthracycline cardiotoxicity
  Pediatric Blood & Cancer, 2005
• Full blockade of intestinal P-glycoprotein and extensive inhibition of blood-brain barrier P-glycoprotein by oral treatment of mice with PSC833.
  Journal of Clinical Investigation, 1997